HEADER VIRAL PROTEIN/INHIBITOR 05-OCT-21 7VLP TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH TITLE 2 PF07321332 IN SPACEGROUP P1211 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PP1A,ORF1A POLYPROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.L.ZHOU,F.L.ZHONG,C.LIN,J.LI,J.ZHANG REVDAT 3 29-NOV-23 7VLP 1 REMARK REVDAT 2 24-AUG-22 7VLP 1 JRNL REVDAT 1 06-APR-22 7VLP 0 JRNL AUTH J.LI,C.LIN,X.ZHOU,F.ZHONG,P.ZENG,Y.YANG,Y.ZHANG,B.YU,X.FAN, JRNL AUTH 2 P.J.MCCORMICK,R.FU,Y.FU,H.JIANG,J.ZHANG JRNL TITL STRUCTURAL BASIS OF THE MAIN PROTEASES OF CORONAVIRUS BOUND JRNL TITL 2 TO DRUG CANDIDATE PF-07321332. JRNL REF J.VIROL. V. 96 01321 2022 JRNL REFN ESSN 1098-5514 JRNL PMID 35389231 JRNL DOI 10.1128/JVI.02013-21 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.355 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 94010 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.135 REMARK 3 FREE R VALUE TEST SET COUNT : 3942 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.4278 - 4.5588 0.99 6591 140 0.1480 0.1576 REMARK 3 2 4.5588 - 3.6199 0.95 6361 128 0.1543 0.1615 REMARK 3 3 3.6199 - 3.1627 0.98 6482 144 0.1867 0.2218 REMARK 3 4 3.1627 - 2.8737 0.99 6622 148 0.2024 0.2081 REMARK 3 5 2.8737 - 2.6678 0.99 6308 141 0.2144 0.2501 REMARK 3 6 2.6678 - 2.5106 0.98 6256 145 0.2084 0.2270 REMARK 3 7 2.5106 - 2.3849 0.99 6618 145 0.2112 0.2517 REMARK 3 8 2.3849 - 2.2811 1.00 6620 142 0.2046 0.2274 REMARK 3 9 2.2811 - 2.1933 0.99 6652 128 0.2076 0.2535 REMARK 3 10 2.1933 - 2.1176 0.99 6545 164 0.2039 0.2719 REMARK 3 11 2.1176 - 2.0514 0.99 6582 134 0.2060 0.2200 REMARK 3 12 2.0514 - 1.9928 0.99 6645 139 0.2053 0.2590 REMARK 3 13 1.9928 - 1.9403 1.00 6642 162 0.2061 0.2290 REMARK 3 14 1.9403 - 1.8930 0.47 3149 64 0.2099 0.2037 REMARK 3 15 1.8930 - 1.8500 1.00 6564 140 0.2071 0.2591 REMARK 3 16 1.8500 - 1.8106 1.00 6632 152 0.1960 0.2160 REMARK 3 17 1.8106 - 1.7744 1.00 6642 154 0.1970 0.2275 REMARK 3 18 1.7744 - 1.7409 1.00 6614 152 0.2007 0.2501 REMARK 3 19 1.7409 - 1.7098 1.00 6672 138 0.2103 0.2369 REMARK 3 20 1.7098 - 1.6808 1.00 6622 122 0.2116 0.2395 REMARK 3 21 1.6808 - 1.6537 1.00 6726 139 0.2222 0.2682 REMARK 3 22 1.6537 - 1.6283 1.00 6545 176 0.2263 0.2676 REMARK 3 23 1.6283 - 1.6043 1.00 6690 138 0.2305 0.2540 REMARK 3 24 1.6043 - 1.5817 1.00 6630 145 0.2404 0.2583 REMARK 3 25 1.5817 - 1.5604 0.99 6561 143 0.2417 0.2462 REMARK 3 26 1.5604 - 1.5401 0.99 6598 133 0.2559 0.2530 REMARK 3 27 1.5401 - 1.5208 0.99 6587 140 0.2607 0.2921 REMARK 3 28 1.5208 - 1.5025 0.98 6581 146 0.2689 0.2638 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.145 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.061 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 4737 REMARK 3 ANGLE : 1.029 6469 REMARK 3 CHIRALITY : 0.109 748 REMARK 3 PLANARITY : 0.006 836 REMARK 3 DIHEDRAL : 9.548 2857 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7VLP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1300024861. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 94054 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 51.635 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.03500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.55600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7CA8 REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN I_PLUS/MINUS COLUMNS. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES 7.5, 20% PEG 10000, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.34750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 GLY B 2 REMARK 465 GLY B 302 REMARK 465 VAL B 303 REMARK 465 THR B 304 REMARK 465 PHE B 305 REMARK 465 GLN B 306 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 TYR A 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 222 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 MET A 276 CG SD CE REMARK 470 LEU A 286 CG CD1 CD2 REMARK 470 GLN A 299 CG CD OE1 NE2 REMARK 470 GLU B 47 CG CD OE1 OE2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ASN B 72 CG OD1 ND2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 100 CG CD CE NZ REMARK 470 LYS B 102 CG CD CE NZ REMARK 470 LYS B 137 CG CD CE NZ REMARK 470 TYR B 154 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 PHE B 223 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 245 CG OD1 OD2 REMARK 470 ARG B 279 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 ARG B 298 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 145 C3 4WI B 401 1.76 REMARK 500 SG CYS A 145 C3 4WI A 401 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 22 CB CYS A 22 SG -0.107 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 3 109.90 -164.13 REMARK 500 ASP A 33 -129.21 53.98 REMARK 500 ASN A 51 71.54 -164.37 REMARK 500 ASN A 84 -119.66 51.46 REMARK 500 MET A 276 -61.68 72.94 REMARK 500 ASN A 277 -104.76 52.41 REMARK 500 ASP B 33 -122.19 50.42 REMARK 500 ASN B 51 75.08 -163.84 REMARK 500 ASN B 84 -125.60 54.94 REMARK 500 ASP B 155 9.63 58.12 REMARK 500 PRO B 184 37.78 -85.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 274 GLY A 275 -143.86 REMARK 500 REMARK 500 REMARK: NULL DBREF 7VLP A 2 306 UNP P0DTC1 R1A_SARS2 3265 3569 DBREF 7VLP B 2 306 UNP P0DTC1 R1A_SARS2 3265 3569 SEQRES 1 A 305 GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU SEQRES 2 A 305 GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU SEQRES 3 A 305 ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG SEQRES 4 A 305 HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN SEQRES 5 A 305 TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE SEQRES 6 A 305 LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY SEQRES 7 A 305 HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP SEQRES 8 A 305 THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG SEQRES 9 A 305 ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR SEQRES 10 A 305 ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG SEQRES 11 A 305 PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER SEQRES 12 A 305 CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SEQRES 13 A 305 SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY SEQRES 14 A 305 VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY SEQRES 15 A 305 PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR SEQRES 16 A 305 ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR SEQRES 17 A 305 ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG SEQRES 18 A 305 PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET SEQRES 19 A 305 LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP SEQRES 20 A 305 ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL SEQRES 21 A 305 LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN SEQRES 22 A 305 GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU SEQRES 23 A 305 GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SEQRES 24 A 305 SER GLY VAL THR PHE GLN SEQRES 1 B 305 GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL GLU SEQRES 2 B 305 GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR LEU SEQRES 3 B 305 ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO ARG SEQRES 4 B 305 HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO ASN SEQRES 5 B 305 TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN PHE SEQRES 6 B 305 LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE GLY SEQRES 7 B 305 HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL ASP SEQRES 8 B 305 THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL ARG SEQRES 9 B 305 ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS TYR SEQRES 10 B 305 ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET ARG SEQRES 11 B 305 PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SER SEQRES 12 B 305 CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS VAL SEQRES 13 B 305 SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR GLY SEQRES 14 B 305 VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR GLY SEQRES 15 B 305 PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY THR SEQRES 16 B 305 ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU TYR SEQRES 17 B 305 ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN ARG SEQRES 18 B 305 PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA MET SEQRES 19 B 305 LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL ASP SEQRES 20 B 305 ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA VAL SEQRES 21 B 305 LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN ASN SEQRES 22 B 305 GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU LEU SEQRES 23 B 305 GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN CYS SEQRES 24 B 305 SER GLY VAL THR PHE GLN HET 4WI A 401 35 HET 4WI B 401 35 HETNAM 4WI (1R,2S,5S)-N-{(1E,2S)-1-IMINO-3-[(3S)-2-OXOPYRROLIDIN- HETNAM 2 4WI 3-YL]PROPAN-2-YL}-6,6-DIMETHYL-3-[3-METHYL-N- HETNAM 3 4WI (TRIFLUOROACETYL)-L-VALYL]-3-AZABICYCLO[3.1.0]HEXANE- HETNAM 4 4WI 2-CARBOXAMIDE HETSYN 4WI PF-07321332, BOUND FORM; NIRMATRELVIR, BOUND FORM; HETSYN 2 4WI PAXLOVID, BOUND FORM FORMUL 3 4WI 2(C23 H34 F3 N5 O4) FORMUL 5 HOH *245(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 GLU A 47 ASN A 51 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 PHE A 66 5 5 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 ASN A 274 1 15 HELIX 11 AB2 THR A 292 SER A 301 1 10 HELIX 12 AB3 SER B 10 GLY B 15 1 6 HELIX 13 AB4 HIS B 41 CYS B 44 5 4 HELIX 14 AB5 THR B 45 ASN B 51 1 7 HELIX 15 AB6 ASN B 53 ARG B 60 1 8 HELIX 16 AB7 LYS B 61 HIS B 64 5 4 HELIX 17 AB8 ILE B 200 ASN B 214 1 15 HELIX 18 AB9 THR B 226 TYR B 237 1 12 HELIX 19 AC1 THR B 243 LEU B 250 1 8 HELIX 20 AC2 LEU B 250 GLY B 258 1 9 HELIX 21 AC3 ALA B 260 GLY B 275 1 16 HELIX 22 AC4 THR B 292 SER B 301 1 10 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 LEU A 67 ALA A 70 -1 N VAL A 68 O LEU A 75 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O VAL A 35 N LEU A 32 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 87 N CYS A 38 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N ILE A 78 O LYS A 90 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O SER A 123 N ALA A 116 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O VAL B 35 N LEU B 32 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 CRYST1 55.484 98.695 59.423 90.00 108.72 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018023 0.000000 0.006108 0.00000 SCALE2 0.000000 0.010132 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017769 0.00000